1. Home
  2. PRU vs TEVA Comparison

PRU vs TEVA Comparison

Compare PRU & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prudential Financial Inc.

PRU

Prudential Financial Inc.

HOLD

Current Price

$124.78

Market Cap

42.4B

Sector

Finance

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$36.61

Market Cap

40.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRU
TEVA
Founded
1875
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.4B
40.5B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
PRU
TEVA
Price
$124.78
$36.61
Analyst Decision
Hold
Strong Buy
Analyst Count
15
8
Target Price
$103.71
$38.63
AVG Volume (30 Days)
1.7M
5.5M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
5.81%
N/A
EPS Growth
33.20
183.45
EPS
4.48
N/A
Revenue
$60,774,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.06
$2.97
P/E Ratio
$27.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$91.89
$17.33
52 Week High
$127.72
$37.39

Technical Indicators

Market Signals
Indicator
PRU
TEVA
Relative Strength Index (RSI) 67.70 66.67
Support Level $99.91 $30.42
Resistance Level $127.72 $37.17
Average True Range (ATR) 2.64 1.04
MACD -0.20 0.34
Stochastic Oscillator 70.37 88.48

Price Performance

Historical Comparison
PRU
TEVA

About PRU Prudential Financial Inc.

Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: